Vimarsana
Biggest News Aggregation in the World

Page 34 - Simulations Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simulations Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simulations Plus Today - Breaking & Trending Today

Simulations Plus, Inc. (SLP) Q2 2022 Earnings Call Transcript - Vimarsana News

Simulations Plus, Inc. (SLP) Q2 2022 Earnings Call Transcript

SLP earnings call for the period ending March 31, 2022.

Source: fool.com
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results - Vimarsana News

Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results

Total revenue growth of 13%; Software revenue growth of 25%; Diluted Earnings Per Share (EPS) growth of 40%Board of Directors announces quarterly dividend of $0.06 per shareLANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services fo...

Simulations Plus (NASDAQ:SLP) Shares Gap Down to $51.69 - Vimarsana News

Simulations Plus (NASDAQ:SLP) Shares Gap Down to $51.69

Simulations Plus, Inc. (NASDAQ:SLP – Get Rating) gapped down before the market opened on Wednesday . The stock had previously closed at $51.69, but opened at $46.54. Simulations Plus shares last traded at $48.39, with a volume of 2,116 shares. Several research firms recently issued reports on SLP. Sidoti began coverage on shares of Simulations […]

118,200 Shares in Simulations Plus, Inc. (NASDAQ:SLP) Purchased by State of Michigan Retirement System - Vimarsana News

118,200 Shares in Simulations Plus, Inc. (NASDAQ:SLP) Purchased by State of Michigan Retirement System

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference - Vimarsana News

Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced record-setting attendance and virtual